NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines, announced ...
Metastatic renal cell carcinoma (mRCC) has seen increased treatment options in recent years, including immunotherapy (IO) combinations paired with tyrosine kinase inhibitors (TKI). A meta-analysis of ...
NEW DELHI: Homegrown telecom gear maker HFCL Thursday signed a nationwide distribution agreement with Beetel Teletech (Beetel) for its ‘IO’ line of products. Under this agreement, Beetel, as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results